Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Income from Continuing Operations (2024 - 2025)

RenovoRx's Income from Continuing Operations history spans 2 years, with the latest figure at 3087000.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 14.16% year-over-year to 3087000.0; the TTM value through Sep 2025 reached 11183000.0, changed N/A, while the annual FY2024 figure was 10586000.0, 6.22% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 3087000.0 at RenovoRx, down from 2545000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 2439000.0 in Q1 2024 and bottomed at 3087000.0 in Q3 2025.